Blue reliever inhalers act quickly to treat symptoms and attacks, and people need to carry them for if their asthma flares up. However, a new warning from the regulator, the UK's Medicines and ...

Triple therapy inhalers are expected to account for 11.3% of the total market. The chronic obstructive pulmonary disease ...

Pressurized metered-dose inhalers (pMDIs) for COPD and asthma contribute to climate change, and countries are moving away from their use.

Ohtuvayre is the first new inhaled COPD therapy approved in over two decades. COPD is a chronic inflammatory condition that ...

One of the most commonly taken drugs in the UK can trigger a debilitating cough that takes up to three months to disappear, a ...